Verition Fund Management
CNST

Verition Fund Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Verition Fund Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-59,651
Closed -$2.02M – 2530
2021
Q2 		$2.02M Buy
+59,651
New +$1.52M 0.02% 520

Verition Fund Management's CNST Position: Q3 2021 in Review

Verition Fund Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 59,651 shares — an estimated $2.02M sold.

Verition Fund Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $2.02M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Verition Fund Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Verition Fund Management sold 59,651 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.02M.
  • Verition Fund Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Verition Fund Management's Constellation Pharmaceuticals, Inc. position peaked at $2.02M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Verition Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.